✦ LIBER ✦

Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome

✍ Scribed by Depil, S; Deconinck, E; Milpied, N; Sutton, L; Witz, F; Jouet, J P; Damaj, G; Yakoub-Agha, I

Book ID: 110014043
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 104 KB
Volume: 33
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704381

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of donor lymphocyte infusions fo

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

✍ Flowers, M E D; Campregher, P V; Gooley, T; Scott, B L; Moravec, C; Sandmaier, B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Sezary syndrome in relapse after reduced

Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion

✍ Cudillo, L; Cerretti, R; Baliva, G; De Angelis, G; Postorino, M; Picardi, A; Mir 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Donor leukocyte infusion after allogenei

Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma

✍ Moritake, H; Ikuno, Y; Tasaka, H; Koga, H; Miyazaki, S; Okamura, J 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 26 KB

Donor lymphocyte infusion induced molecu

Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation

✍ Au, W Y; Lie, A K W; Lee, C K; Liang, R; Kwong, Y L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Donor cell myelodysplastic syndrome afte

Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: Case report and literature review

✍ Rami Komrokji; Jainulabdeen J. Ifthikharuddin; Raymond E. Felgar; Camille N. Abb 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to re‐emergence of a recipient derived, neoplastic, stem cell clone

Myeloid leukemia and myelodysplastic syn

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

✍ A. Szomor; J. R. Passweg; A. Tichelli; T. Hoffmann; B. Speck; A. Gratwohl 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 139 KB